News

Caixa Capital Risc invests in MealFood Europe, the leading start-up in the industrial insect production sector in Spain

• The CriteriaCaixa venture capital manager and the CDTI Innvierte Economia Sostenible will have 40% of the capital of the Salamanca start-up.
• MealFood Europe is a benchmark company in Europe, specialised in the industrial breeding of insects for animal feed.
• Caixa Capital Risc manages a volume of more than 210 million euros in over 120 innovative companies in Spain and Portugal.

| Read more |

Catalan startup Validated ID participates in a global initiative to develop coronavirus immune passports

Catalan startup Validated ID offers free digital signatures during quarantine and participates in a global initiative to develop coronavirus immune passports.

| Read more |

Initiatives to support people and companies to overcome Covid-19 crisis

The COVID-19 crisis is forcing individuals and companies to adapt fast to new challenges. In this context, several companies are promoting solidarity initiatives and projects to overcome this crisis in the best possible conditions.

| Read more |

Validated ID closes a round led of 2 million Euros from Caixa Capital Risc, Randstad y Cuatrecasas [Article in spanish]

(Español) La compañía barcelonesa especializada en firma electrónica, factura electrónica e identidad digital ha cerrado esta nueva ronda de financiación que consolida su plan de crecimiento y expansión en el mercado internacional. La inversión de 2M€ permitirá también su consolidación en el emergente mercado de las identidades digitales basadas en blockchain (SSI).

| Read more |

Caixa Capital Risc is leading the largest operation in the biotech sector in Spain, with a €55 million financing round in Sanifit

• The financing ends with a loan capitalisation of €17 million, which brings the total of the operation to 72.2 million.
• It will speed up research into SNF472, a drug designed to treat a rare disease known as calciphylaxis.
• Two new investors are joining the company: Columbus Venture Partners and Alta Life Sciences.

| Read more |